Replies to post #431069 on Anavex Life Sciences Corp (AVXL)

[kund]

First time adverse event were disclosed in 2020 for Phase2a in peer review paper supplement. 2a Trial was complete 2015 and company disclosed adverse event after 5 year. I think WGT crowd's beloved TGD is not forthcoming, he is trying his best to hide data either by using delaying tactics or changing end points post-hoc.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167374/